Ranata Therapeutics builds antibodies and bispecific antibodies against the unique features of an individual patient's cancer cells.
Ranata Therapeutics harnesses the uniqueness of a patient's cancer cells to build biologic therapies, antibodies or bispecifics, against that cancer: personalised medicine inspired by the individual's biology. It is an Even One Ventures portfolio company with no published candidates.
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
Shares Even One Ventures and the tags startup, evenone-portfolio.
Shares Even One Ventures and the tags startup, evenone-portfolio.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/